Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer: a systematic review

被引:85
|
作者
Holly R. Harris
Kathryn L. Terry
机构
[1] Fred Hutchinson Cancer Research Center,Program in Epidemiology, Division of Public Health Sciences
[2] Brigham and Women’s Hospital and Harvard Medical School,Department of Obstetrics and Gynecology
[3] Harvard T.H. Chan School of Public Health,Department of Epidemiology
关键词
Polycystic ovary syndrome; Endometrial cancer; Ovarian cancer; Breast cancer;
D O I
10.1186/s40738-016-0029-2
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [31] Evaluating the association between endometrial cancer and polycystic ovary syndrome
    Haoula, Zeina
    Salman, Maisa
    Atiomo, William
    [J]. HUMAN REPRODUCTION, 2012, 27 (05) : 1327 - 1331
  • [32] POLYCYSTIC OVARY SYNDROME PREDICTS PROGNOSIS IN ENDOMETRIAL CANCER PATIENTS
    Uehara, T.
    Mitsuhashi, A.
    Hanawa, S.
    Yamamoto, N.
    Nishikimi, K.
    Tate, S.
    Usui, H.
    Shozu, M.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 1508 - 1508
  • [33] A study of the relationship between polycystic ovary syndrome and endometrial cancer
    Pillay, O. C.
    Wong, L. F.
    Fong, T. E.
    Crow, J. C.
    Benjamin, E.
    Mould, T.
    Atiomo, W.
    Menon, P. A.
    Leonard, A. J.
    Sharkey, A.
    Catalano, R.
    Hardiman, P.
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (07) : 856 - 856
  • [34] The polycystic ovary syndrome and gynecological cancer risk
    Meczekalski, Blazej
    Perez-Roncero, Gonzalo R.
    Lopez-Baena, Maria T.
    Chedraui, Peter
    Perez-Lopez, Faustino R.
    [J]. GYNECOLOGICAL ENDOCRINOLOGY, 2020, 36 (04) : 289 - 293
  • [35] The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism
    Holm, Nina Sofie Lillegaard
    Glintborg, Dorte
    Andersen, Marianne Skovsager
    Schledermann, Doris
    Ravn, Pernille
    [J]. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 2012, 91 (10) : 1173 - 1176
  • [36] Breast cancer risk in patients with polycystic ovary syndrome: A Mendelian randomization analysis
    Wu, X.
    Wen, Y.
    Peng, H.
    Li, C.
    Liang, H.
    He, J.
    Liang, W.
    [J]. ANNALS OF ONCOLOGY, 2020, 31 : S335 - S335
  • [37] The Role of mTOR in Ovarian Cancer, Polycystic Ovary Syndrome, and Ovarian Aging
    Liu, Jin
    Wu, Dai-Chao
    Qu, Li-Hua
    Liao, Hong-Qing
    Li, Mei-Xiang
    [J]. CLINICAL ANATOMY, 2018, 31 (06) : 891 - 898
  • [38] Polycystic ovary syndrome: Endometrial markers
    Piltonen, Terhi T.
    [J]. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2016, 37 : 66 - 79
  • [39] Polycystic ovary syndrome and endometrial carcinoma
    Hardiman, P
    Pillay, OS
    Atiomo, W
    [J]. LANCET, 2003, 361 (9371): : 1810 - 1812
  • [40] Breast cancer risk in patients with polycystic ovary syndrome: a Mendelian randomization analysis
    Wen, Yaokai
    Wu, Xiangrong
    Peng, Haoxin
    Li, Caichen
    Jiang, Yu
    Su, Zixuan
    Liang, Hengrui
    Liu, Jun
    He, Jianxing
    Liang, Wenhua
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2021, 185 (03) : 799 - 806